ArticleOncotarget2015
VE1 immunohistochemistry predicts BRAF V600E mutation status and clinical outcome in colorectal cancer.
Christian Schafroth et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this paperpooled itcites it